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October 2009968 AbstractsTable. Summary of findings comparing patients with and
without limb ischemia
Age
(years)
Male
Gender BSA (m2) BMI
Cannula
Size (Fr)
Mortality
(%)
Limb ischemia 36  18 7/7 2.09  0.29 29.5  10.0 16.9  1.1 4/7 (57)
No limb
ischemia
58  14 20/26 2.13  0.27 30.8  5.4 18.0  1.7 23/26 (88)
Prophylactic-Y 44  16 7/10 2.06  0.23 29.4  9.0 17.7  1.8 7/10 (70)
P-value* 0.001 0.30 0.57 0.65 0.09 0.09
BMI, Body mass index; BSA, body surface area.
*Between “limb ischemia” and “no limb ischemia” groups.
Does the Addition of Routine IVC/Iliac Vein and Infrapopliteal
Duplex Scan Confer any Benefit?
Alhabouni S, Hingorani A, Ascher E, et al
Objectives: The routine evaluation for lower extremity deep vein
thromboses (DVT) usually involves the femoral and popliteal veins with no
regard to the more proximal (Iliac and inferior vena cava [IVC]) veins or the
more distal (infra-popliteal) veins. In this study, we attempted to evaluate
the benefits of routine scanning of these segments.
Methods: We reviewed 1624 consecutive lower extremity venous
duplex studies performed for 1513 of our in-house patients between January
2008 and July 2008. All studies included routine evaluation of the IVC/iliac
and infra-popliteal vein segments. All studies were also evaluated for any
evidence of pulmonary embolism (PE).
Results: The IVC/iliac vein segments were completely evaluated in
1270 duplex studies with evidence of IVC/iliac vein DVTs in 37 (2.9%). In
354 studies, the evaluation was incomplete due to improper visualization of
the IVC mostly due to bowel gas. Despite that, evidence of iliac vein DVT
was noted in 18 (5.1%) of these studies. In total, the addition of routine iliac
vein/IVC duplex scan resulted in the detection of 55 (3.38%) DVTs with
evidence of PE in five (incidence of 9.1%). In five of those 55 duplex studies,
the IVC/iliac vein DVT was the only DVT detected, with evidence of PE in
one (incidence of 20%). The rest of the study population had evidence of
DVT in 244 studies (15.55%) with evidence of PE in 32 (incidence of
13.1%) of them (P  .59). Infra-popliteal segment: 145 infra-popliteal
DVTs were detected, of which 50 (34.5%) were isolated to the infra-
popliteal segments with evidence of PE in three (incidence of 6%). The rest
of the study population showed evidence of DVT in 98 with evidence of PE
in 14 (incidence of 14.3%) (P  .135).
Conclusions: Although routine scanning of the IVC/Iliac veins re-
sulted in detection rate of 3.38%, the detection of an isolated DVT in those
veins was very low (0.3%). However, isolated DVT of the iliac veins had a PE
rate of 20%. As for the routine scanning for infra-popliteal DVTs, 50
additional DVTs were detected with a PE rate of 6%, with no statistical
difference from the rate of PE from more proximal segments (P  .135).
Hence infra-popliteal DVTs should be regarded as risky as more proximal
DVTs and should therefore be treated similarly.
Mechanical-Chemical Endovenous Ablation: A New Tumescentless
Technique
Elias S
Objectives: The minimally invasive management of vein disease contin-
ues to evolve. Endothermal methods to ablate the great and small saphenous
veins involve the use of tumescent anesthesia for analgesia and compressionwith
possible adjunctive intravenous sedation. Foam sclerotherapy of the great and
small saphenous veins has been attempted with mixed results. A new en-
dovenous device that does not require tumescent anesthesia or intravenous
sedation, ClariVein (Vascular Insights LLC, Conn), was evaluated. The Clar-
iVein catheter utilizes endovenous mechanical vein wall destruction with a
rotating wire and the simultaneous infusion of a liquid sclerosant (Sotradecol)
to enhance venous ablation. This endovenous mechanical treatment is unique.
This Institutional Review Board-sanctioned study evaluated the safety and
efficacy of this technique.
Methods: The ClariVein device was utilized in 30 patients with great
saphenous vein incompetence. All procedures were performed in office with
only local anesthesia at the access site. No tumescent anesthesia or intrave-
nous sedation was employed. Ultrasound guidance similar to other en-
dovenous procedures was used. Post treatment care was similar to en-
dovenous thermal ablative procedures.
Results: Total procedure time was less than 15 minutes. Access was at
the lowest level of incompetence but no lower than below the knee. Results
at one week, one month, and three months will be presented including
occlusion rates greater than 90%. Complication rates and symptom resolu-
tion will be discussed.Conclusions: The unique endomechanical ablative aspect of the Clar-
iVein coupled with a safe FDA approved liquid sclerosant represents a furthersimplification and advancement in the treatment of venous disease. This is
accomplished without the tumescent anesthesia currently required for endo-
thermal methods and an early success rate comparable to these methods.
Endovenous Ablation plus Microphlebectomy/Sclerotherapy for the
Treatment of Varicose Veins: A Single or Two-Stage Procedure?
Schanzer H
Objectives: Endovenous ablation (EVA) of the saphenous vein has
almost completely replaced surgical stripping for the treatment of saphenous
vein reflux. In contrast to stripping that includes microphlebectomy, EVA is
generally performed in two stages (ablation followed, when needed, by
microphlebectomy or sclerotherapy). The purpose of this study was to
determine how often second stage procedures are required after EVA.
Methods: All consecutive patients undergoing laser EVA between
March 2007 andDecember 2008 were enrolled. At presentation, the clinical
severity of venous insufficiency was graded according to CEAP classification.
Patients were examined clinically/ultrasound at one week, and clinically at
one month. Varicose vein resolution following EVA was classified as excel-
lent (no varicosities), good (major reduction in size), and poor (no change).
Need for further intervention was determined at the one month follow-up.
Results: During the study period, 86 lower extremities in 76 patients
were treated with laser EVA (50 females, 26males, mean age 50 15 years).
By CEAP classification, 75 extremities were C2 (87.2%), five were C4
(5.8%), two were C5 (3.5%), and two were C6 (3.5%). Greater saphenous
veins were treated in 72 extremities (83.7%), small saphenous veins in 10
extremities (11.6%), anterior branch of the greater saphenous vein in two
extremities (2.3%), and both the greater saphenous vein and anterior branch
in two extremities (2.3%). The mean vein treatment length was 26.3  9.7
cm with a mean energy delivery of 64  11.3 Joules. At one week, all 86
extremities had the treated segment of vein closed and one of them had
partial extension of clot to the common femoral vein (1.16% incidence of
deep vein thrombosis [DVT]). At one month, complete resolution of
varicosities was found in 36 extremities (41.8%), reduction in size in 48
extremities (55.8%), and no improvement in two extremities (2.3%). Of the
patients with remaining varicosities, 15 extremities (17.4%) had small per-
sistent asymptomatic varicose veins of no concern to the patient. The
remaining 35 extremities (40.7%) required a second stage procedure.
Conclusions: After EVA, 59.3% of extremities did not require any
further treatment. These results justify the performance of EVA alone as a
first stage, as the majority of patients will be spared unnecessary microphle-
bectomy or sclerotherapy.
Evaluating the Availability of On-call Venous Duplex Scanning: ANew
Paradigm for Efficient Use of the Vascular Lab
Arnaoutakis G, Pirruccello J, Brooke B, Reifsnyder T
Objectives: Venous duplex ultrasound (VDU) is the standard evalua-
tion for acute deep vein thrombosis (DVT). Having the test available at all
hours imposes significant costs and universal availability may be unnecessary.
The purpose of this study was to compare the treatment and outcomes of
patients with suspectedDVT before (2005) and after (2007) eliminating the
availability of 24-hour VDU.
Methods: A retrospective cross-sectional study was performed among
patients evaluated by the emergency department (ED) for suspected DVT
during the years 2005 and 2007. The association of clinical variables, VDU
results, treatment, and complications were compared between time periods
using bivariate and multivariate regression models following propensity
score matching.
Results: In 2005 and 2007, 320 and 366 patients, respectively, had
VDU after referral by the ED. There were 31 acute DVTs in 2005 and 25 in
2007. There was no detected difference in thromboembolic complications.
Forty-nine (16%) tests during 2005 were done after hours. The number of
patients treated empirically before confirmation of DVT was significantly
higher in 2007: 51 (14%) vs 26 (8%) (P .019). Empiric treatment was also
more frequent in 2007 in patients confirmed to have acute DVT: seven
(28%) vs. three (7%) (P  .023). After matching patients by propensity
scores, regression models revealed a trend toward increased likelihood of
empiric treatment if patients had risk factor(s) known to indicate high risk for
DVT. There were no documented complications from empiric anti-coagu-
lation. Estimated savings for one year were $27,000.
Conclusions: The data suggest that elimination of around-the-clock
VDU services can render substantial savings to hospitals with no adverse
consequence in the acute management of DVT.
Long Term Functional Results of the Surgical Management of Neuro-
genic Thoracic Outlet Syndrome (NTOS)
Scali ST, Stone DH, Bjerke AA, Chang CK, Rzucidlo EM, Walsh DBObjectives: To document long-term functional outcomes in patients
treated for neurogenic thoracic outlet syndrome (NTOS).
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our center were reviewed. Patient demographics and co-morbidities were
recorded. End-points included symptomatic relief, peri-operative adjunctive
procedures, functional outcome, and employment continuity.
Results: From 1988-2008, 26 patients were operated upon for NTOS.
Hallmarks of the diagnosis in operated patients included symptom duration less
than one year and positive Roos test. Patients receiving disability and those with
cervical spine pathology were not considered for surgery. Mean patient age was
39.2 years (range, 14-60 years) with amean follow-up of 104.4months. Eleven
patients (42.3%) engaged in pre-operative physical therapy programs. Seven of
nine patients (26.9%) received adjunctive peri-procedural scalene block with
temporary symptom relief. All patients underwent thoracic outlet decompres-
sion by either first rib resection (18 total: 8 [44%] transaxillary and 10 [66%]
supraclavicular), cervical rib resection (6 [26.1%]), and/or scalenectomy (12
[46.2%]). Of the 22 patients available for follow-up, six patients (27.3%) have
required continued postoperative narcotic analgesics. Sixteen patients (72.7%)
returned to work and reported being at an equivalent or better functional
outcome than their pre-operative status.
Conclusions:Durable long-term functional outcomes can be achieved
predicated on a highly selective approach to the surgical management of
patients with NTOS. A majority of operated patients will not require
adjunctive procedures or chronic narcotic utilization. Patients who undergo
surgery can expect to return to work with little or no functional impairment.
The Effect of Surgical Technique on theMidterm Functional Outcome of
Brachiocephalic Arteriovenous Fistulas: One Incision vs Two Incisions
Costanza M, Stein J, DiRocco J, Ehsani-Chimeh N, Amankwah K, Gahtan V
Objectives: Surgery to create a brachiocephalic arteriovenous fistula
(BCAF) can be performed through one transverse incision distal to the
antecubital fossa or two parallel incisions on the upper arm, proximal to the
antecubital fossa. The prevailing wisdom holds that the choice of one or two
incisions should not affect fistula outcome; however, this assumption has
never been formally evaluated. We compared the functional patency of
BCAF that were created using one vs. two incisions.
Methods:We reviewed the records of all patients who had BCAF surgery
by our division over the last five years. The choice of one or two incisions
depended on surgeon preference. Patients who had BCAF surgery but never
starteddialysiswere excluded. Functional patencywas defined as the timeperiod
during which the fistula was used for hemodialysis. Cumulative functional
patency was the sum of primary, assisted, and secondary functional patency and
the two groups were compared using life table analysis.
Results:We constructed 126 BCAF; 11 patients have yet to start dialysis,
leaving 115 patients as the study population. A total of 50 patients had one
incision and 65 patients had two incisions. At one month follow-up, all fistulas
in both groupswere clinically patent. The fistulawas never used for dialysis in 15
(30%) patients with one incision and in 18 (27%) patients with two incisions. In
both groups, the most common reason for abandonment was non-maturation.
By life table analysis (Fig), fistulas constructed using two incisions had a
significantly longer median cumulative functional patency than fistulas con-
structed using one incision (26 1.1 months vs. 9 1.3 months; P .005).
Conclusions: This non-randomized series suggests that surgical tech-
nique has an effect on fistula function. BCAF constructed using two incisions
demonstrated superior functional patency compared with BCAF constructed
using one incision. The two-incision approach places the arteriovenous anasto-
mosis more proximally on the upper arm compared with the one-incision
approach inwhich the anastomosis is distal to the antecubital fossa.We speculate
that the quality of the artery and vein at this more proximal location could
explain the better durability of the two-incision technique.Fig. Cumulative patency for brachiocephalic AV fistulas.Declotting of Arteriovenous Hemodialysis Acssess: A Comparison of
Percutaneous Mechanical Thrombectomy and Angioplasty versus
Open Thrombectomy
Nahmias JT, Schanzer A, Messina LM, Eslami MH
Objectives: Maintaining patency of arteriovenous hemodialysis access
(AVHA) inmore than 25,000 patients is very costly. This studywas set to compare
the length of stay (LOS), hospital charges, and secondary patency rates of percuta-
neous mechanical thrombectomy (PMTA) versus open thrombectomy (OT).
Methods: A retrospective chart review analysis of a single institution
AVHA thrombectomy cases; 77OT and 36 PMTA cases from 2002 to 2008
were reviewed. We compared the mean and median LOS, mean and median
secondary patency rates, and mean hospital charges. Statistical analyses were
performed using t test and data was significant if P  .05.
Results: OT had a mean LOS of five days, mean hospital charges of
$30,750, and a mean secondary patency of 70 days. PMTA had a mean LOS
of two days, mean hospital charges of $30,006, and a mean secondary
patency of 73 days.
Conclusions: There is a higher mean secondary patency rate and lower
hospital charges for PMTA. Additionally, PMTA had a statistically signifi-
cant lower mean LOS compared with OT (P .0002). Given the significant
less LOS, less charges, and higher patency rates, we concluded that PMTA is
a superior option for AVHA thrombectomy. Cost effectiveness would
require a multi-center prospective randomized trial.
The Effect of Immunosuppression on Lower Extremity Arterial Bypass
Outcomes
Grisafi JL, Dadachanji C, Rahbar R, Muluk SC, Benckart DH
Objectives:Myointimal hyperplasia is a pathologic result of the body’s
natural inflammatory response to blood vessel injury and a leading cause of
early peripheral arterial bypass failure. Since immunosuppressive agents are
known to abate inflammation, we hypothesized superior outcome of lower
extremity bypass in subjects of renal transplantation compared with the
hemodialysis population.
Methods: The vascular surgery registry at a single tertiary care center
was retrospectively reviewed to identify recipients of lower extremity bypass
procedures. All patients with a history of renal transplantation (RT group)
were selected for analysis. The indication of acute arterial occlusion resulted
in exclusion from analysis. Bypass patients with dialysis dependent renal
failure (RF group) were randomly selected to provide a matched control
cohort. Amputation-free survival was the primary endpoint.
Results: See Table for demographics and results. Vascular reconstruction
for chronic peripheral vascular disease (PVD) yielded an amputation-free sur-
vival rate of 80% at one year for theRFgroup comparedwith only 22% in theRT
group (P  .02). There was no statistically significant difference between the
groups in mortality at 30 days and one year, indication for operation, or
comorbid conditions. Indications for operation included severe claudication
(n  1), rest pain (n  1), and tissue loss (n  17). Interestingly, vascular
reconstruction on the extremity ipsilateral to the allograft was required in 67%of
the transplant patients; however, this observationwas not statistically significant.
Conclusions: The results of this study suggest a deleterious effect of
immunosuppression on outcome of lower extremity bypass procedures at
the dosing levels required to prevent allograft rejection. This finding, which
has been scarcely reported, underscores the importance of pre-transplant
PVD screening and timely reconstruction when clinically indicated.
Table. Demographics and results
RT (n  9) RF (n  10) P value
Mean age 54 years 66 years .04
DM 89% 90% 1.0
HTN 100% 100% 1.0
Smoker 0% 44% .08
BMI 27.3 26.4 .78
Prosthetic 11% 40% .3
Amputation-free survival 22% 80% .02
BMI, Body mass index; DM, diabetes mellitus; HTN, hypertension.
Multilevel Versus Isolated Tibial Interventions for Critical Limb Ischemia
Fernandez N, Marone L, Rhee R, Leers S, Makaroun MS, Chaer R
Objectives:Endovascular interventions for critical limb ischemia (CLI)
continue to have variable outcomes. The purpose of this study is to deter-
mine the anatomic predictors of failure for tibial interventions.
